CELLECT BIOTECHNOLOGY LTD (APOPXXXX)
Institutional ownership reported to the SEC as of Q2 2026, across 22 quarters.
1
Reporting holders
$6
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| HUNTINGTON NATIONAL BANK | $6 | 1 | 0.00% | 15q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $6 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $6 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 1 | $6 | 1 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 1 | $6 | 1 | 0 | 0 | 0 | 0.0% |
| Q2 2025 | 1 | $6 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2025 | 1 | $6 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2024 | 1 | $6 | 1 | 0 | 0 | 0 | 0.0% |
| Q3 2024 | 1 | $6 | 1 | 0 | 0 | 0 | 0.0% |
| Q2 2024 | 1 | $6 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2024 | 1 | $6 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2023 | 1 | $6 | 1 | 0 | 0 | 0 | 0.0% |
| Q3 2023 | 1 | $6 | 1 | 0 | 0 | 0 | 0.0% |
| Q2 2023 | 1 | $6 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2023 | 1 | $6 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2022 | 1 | $6 | 1 | 1 | 0 | 0 | 0.0% |
| Q2 2021 | 6 | $630.0K | 168,312 | 1 | 1 | 3 | 0.0% |
| Q1 2021 | 10 | $680.6K | 216,877 | 8 | 0 | 2 | 0.0% |
| Q4 2020 | 2 | $342.0K | 158,177 | 0 | 0 | 1 | 0.0% |
| Q3 2020 | 6 | $664.0K | 315,602 | 3 | 1 | 2 | 0.0% |
| Q2 2020 | 5 | $949.0K | 301,236 | 1 | 2 | 0 | 0.0% |
| Q1 2020 | 5 | $285.4K | 194,166 | 0 | 2 | 0 | 0.0% |
| Q4 2019 | 7 | $285.7K | 128,340 | 5 | 0 | 0 | 0.0% |